Medications for Acquired Thrombotic Thrombocytopenic Purpura

4 results

  • Octaplas (human plasma proteins)

    (human plasma proteins)
    Octapharma USA Inc
    Usage: Octaplas is indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease, as well as for use during cardiac surgery, liver transplantation, and plasma exchange in thrombotic thrombocytopenic purpura (TTP).

  • Octaplas (human plasma proteins)

    (human plasma proteins)
    Octapharma USA Inc
    Usage: Octaplas is indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease, during cardiac surgery and liver transplantation, as well as for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).

  • Octaplas (human plasma proteins)

    (human plasma proteins)
    Octapharma USA Inc
    Usage: Octaplas is indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease, during cardiac surgery, and liver transplantation, as well as for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).

  • Octaplas (human plasma proteins)

    (human plasma proteins)
    Octapharma USA Inc
    Usage: Octaplas is indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease, and for use during cardiac surgery and liver transplantation. It is also used for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).